Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-24-239617
Filing Date
2024-10-18
Accepted
2024-10-18 16:01:01
Documents
17
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d825263d10qa.htm   iXBRL 10-Q/A 50417
2 EX-31.1 d825263dex311.htm EX-31.1 7524
3 EX-31.2 d825263dex312.htm EX-31.2 7524
  Complete submission text file 0001193125-24-239617.txt   265419

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cnta-20240630.xsd EX-101.SCH 4790
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnta-20240630_cal.xml EX-101.CAL 655
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20240630_def.xml EX-101.DEF 16741
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20240630_lab.xml EX-101.LAB 22536
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20240630_pre.xml EX-101.PRE 17775
19 EXTRACTED XBRL INSTANCE DOCUMENT d825263d10qa_htm.xml XML 6960
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40445 | Film No.: 241380727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)